Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023

BUY
$241.42 - $282.29 $12,071 - $14,114
50 Added 4.06%
1,281 $0
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $12,353 - $75,370
50 Added 4.23%
1,231 $318,000
Q2 2022

Jul 20, 2022

SELL
$237.11 - $299.66 $15,412 - $19,477
-65 Reduced 5.22%
1,181 $300,000
Q1 2022

May 04, 2022

BUY
$257.27 - $315.76 $65,346 - $80,203
254 Added 25.6%
1,246 $366,000
Q4 2021

Jan 24, 2022

BUY
$292.08 - $329.01 $3,212 - $3,619
11 Added 1.12%
992 $327,000
Q2 2021

Jul 26, 2021

BUY
$225.08 - $271.69 $220,803 - $266,527
981 New
981 $263,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.